Kite Pharma
American biotechnology company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Allogene Therapeutics?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Quick Facts Company type, Industry ...
Company type | Subsidiary |
---|---|
Industry | Biopharmaceutical |
Founded | 2009; 15 years ago (2009) |
Founder | Arie Belldegrun and Joshua Kazam |
Fate | Acquired by Gilead Sciences |
Headquarters | , |
Key people |
|
Products | Cancer immunotherapy |
Number of employees | 2,000 |
Parent | Gilead Sciences |
Website | www.kitepharma.com |
Footnotes / references Key People,[2][3] Founder[3][1] |
Close